Summary Systemically administered radiolabelled anti-tumour antibody is ineffective in treating the majority of patients with liver metastasis from colorectal carcinoma. We have assessed whether agents which increase capillary permeability can increase tumour uptake of antibody isotope conjugate. We developed a xenograft model of colorectal carcinoma using an antibody directed against carcinoembryonic antigen (CEA). Tumours were grown subcutaneously in the hind limbs of athymic rats to derive their circulation from the femoral artery. Cannulae were placed in the common iliac artery and iliolumbar vein. Antibody was delivered systemically, regionally and regionally with histamine, leukotriene C4 and interleukin-2.
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Regionally administered anti-CEA antibody resulted in a significantly greater (P = 0.004) tumour to normal tissue ratio ( Treatment of disseminated colorectal carcinoma using systemically administered anti-tumour antibody labelled with a therapeutic dose of iodine 131 has produced poor responses (Begent et al., 1989) because of low tumour antibody uptake. The uptake of antibody from the circulation depends on intravascular dose, tumour blood flow (Sands et al., 1986) and capillary permeability (Sands et al., 1988) . In the case of antibody macromolecules (IgG, molecular weight 150,000 daltons) capillary permeability is an important limitation to tissue uptake (Halpern et al., 1986; Sands et al., 1985) .
We assessed the value of increasing capillary permeability by using agents known to increase capillary permeability in normal tissues. The agents selected were the vasodilator autocoid histamine (Douglas, 1980) , the vasoconstrictor eicosanoid leukotriene C4 (Frolich & Yoshizawa, 1987; Goetz et al., 1987; Badr, 1984) and the biological response modifier interleukin-2 (Rosenstein et al., 1986) which has minimal influence on vasomotor tone. Since these agents all have a short half life, they were administered regionally to enhance local effect and reduce systemic toxicity.
To assess whether these agents could increase uptake of antibody, we first developed a xenograft model which allows cannulation of tumour circulation and regional infusion of antibody to a human colorectal carcinoma expressing carcinoembryonic antigen (CEA).
Methods
Two antibody conjugates were prepared: specific anti-CEA antibody (A5B7) labelled with iodine 131 and non-specific antibody (anti-HCG antibody, SB 10) labelled with iodine 125. Both were labelled using the chloramine T method (Greenwood et al., 1963) .
Genetically immunocompromised rats (150-200 g) were maintained in a negative pressure isolator (Isotec, Bicester) and fed on sterile water and irradiated feed ad libitum. One million cells from a human colon cancer cell line (LS174T) in 0.1 ml of complete medium (Gibco, Uxbridge) were injected subcutaneously into the mid-thigh of the hind limb. Once solid tumour had grown the tumour line was serially passaged by implanting diced fragments of these tumours (mean weight 15mg) into the subcutaneous fat of the hind limb. Arteriography confirmed that the tumours grew to derive their blood supply from the femoral artery (Figure 1 ). Br. J. Cancer (1991), 64, 872-874 (C) Macmillan Press Ltd., 1991 When 300-600 mg tumours, determined by calliper measurements and volume approximation (Staab & Anderer, 1982) had grown the animal was anaesthetised the two cannulae (Portex 0.4mm internal diameter, Arterial Medical Supplies, London) were inserted via a laparotomy incision. The first ('venous' or 'systemic') cannula was inserted into the right iliolumbar vein so that its tip lay at the junction of the iliolumbar vein and the inferior vena cava to gain access to the systemic circulation. The second ('arterial' or '6regional') cannula was passed retrogradely into the right common iliac artery so that its tip lay at the aortic bifurcation to gain -access to the arterial supply to the contralateral tumour-bearing limb.
Antibody was then administered. In 24 animals the infusion of anti-carcinoembryonic antigen antibody (A5B7) labelled with iodine 131 was delivered into the systemic cannula with an infusion of saline delivered regionally. In 24 animals the situation was reversed and the conjugate delivered regionally with a control infusion of saline given systemically. In 30 animals the conjugate was mixed with histamine (Sigmna, 5 mg kg-', n = 12), leukotriene C4 (Sigma, 25 mcg/animal, n = 8) or interleukin-2 (100,000 units/animal, n = 10) and then delivered regionally. The agents were prepared in degassed phosphate buffer at pH 7.4.
After a 1 h infusion, the abdomen was re-opened and the cannulae removed, carefully preserving flow to the tumour bearing limb and the animal was then recovered. After 48 h the animnal was again anaesthetised and the liver and tumour excised and weighed. Liver and tumour radioactivity was measured in a well counter to determine a tumour to liver gamma counts ratio.
Results
The tumour to liver ratio of counts obtained in each group is shown in Figure 2 .
Tumour to liver ratio of non-specific antibody Regional delivery was used primarily as a means of delivering short-acting vasoactive agents to the tumour circulation. We found that agents which increase capillary permeability in normal capillaries increased the uptake of antibody. Our study does not prove that the mechanisms of this increase was change in capillary permeability. However, each of the agents used has a different effect on microcirculation resistance and the effect observed was of a similar order of magnitude for all three agents. As increase in capillary permeability was the common factor, this is a likely explanation for the observed increase in antibody uptake.
This suggests that these agents are capable not only of influencing capillary permeability in normal tissues but also in the tumour circulation where capillaries are more rudimnentary and varied in structure (Tannock & Steel, 1969; Vaupel, 1975) . The finding that a similar effect was observed for non-specific antibody is compatible with enhancement of capillary permeability. However the smaller increase compared with specific antibody suggests that antigen-antibody binding contributed to the tumour labelled-antibody concentration.
The use of agents which increase capillary permeability in normal tissues can achieve an approximate 3-fold increase in specific antibody uptake. If radioimmunotherapy is to be effective, a 10-fold increase in antibody uptake relative to normal tissue may be required (Dykes et al., 1987) although more modest increases may be of value in some patients (Begent et al., 1989) . The increase seen in this study, using regional delivery of agents which increase capillary permeability in normal tissues, is of sufficient magnitude to offer a prospect of therapeutic benefit if these findings were to be reproduced in man. 
